These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3872170

  • 1. Phase II trial of diaziquone in advanced ovarian carcinoma. European Organization for Research on Treatment of Cancer Early Clinical Trials Group.
    Lund B, Bramwell V, Renard J, Hansen HH, Dombernowsky P.
    Cancer Treat Rep; 1985 Mar; 69(3):339-40. PubMed ID: 3872170
    [No Abstract] [Full Text] [Related]

  • 2. Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.
    Slayton RE, Blessing JA, Sutton GP, Homesley HD, Park R.
    Cancer Treat Rep; 1986 Feb; 70(2):309-10. PubMed ID: 3948196
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
    Chiuten DF, Umsawasdi T, Dhingra HM, Murphy WK, Spitzer G, Carr DT, Bodey GP, Valdivieso M.
    Cancer Treat Rep; 1985 Feb; 69(7-8):921-2. PubMed ID: 4016800
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phase II study of aclarubicin and diaziquone in the treatment of advanced small cell bronchogenic carcinoma (EST 4581): an Eastern Cooperative Oncology Group Study.
    Abeloff MD, Finkelstein DM, Chang AY, Camacho FJ, Creech RH, Ettinger DS.
    Cancer Treat Rep; 1985 Apr; 69(4):451-2. PubMed ID: 3857972
    [No Abstract] [Full Text] [Related]

  • 7. Phase II study of diaziquone in patients with advanced carcinoma of the lung.
    Frytak S, Eagan RT, Creagan ET, Nichols WC.
    Cancer Treat Rep; 1984 Sep; 68(9):1193-4. PubMed ID: 6478455
    [No Abstract] [Full Text] [Related]

  • 8. Phase II trial of diaziquone in anthracycline-resistant adult soft tissue and bone sarcoma patients: a Southeastern Cancer Study Group Trial.
    Chan C, Bartolucci A, Brenner D, Presant C, Davila E, Carpenter J, Greco FA, Clamon G, Moore J.
    Cancer Treat Rep; 1986 Mar; 70(3):427-8. PubMed ID: 3456834
    [No Abstract] [Full Text] [Related]

  • 9. Phase II evaluation of diaziquone in recurrent head and neck cancer.
    Kish JA, Ensley J, Al-Sarraf M.
    Cancer Treat Rep; 1986 May; 70(5):671-2. PubMed ID: 3708616
    [No Abstract] [Full Text] [Related]

  • 10. Phase II trial of diaziquone in malignant mesothelioma.
    Eagan RT, Frytak S, Richardson RL, Creagan ET, Nichols WC.
    Cancer Treat Rep; 1986 Mar; 70(3):429. PubMed ID: 3955559
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of diaziquone in advanced soft tissue and bony sarcoma: a Southwest Oncology Group study.
    Zidar BL, Baker LH, Rivkin SE, Balcerzak SP, Stephens RL.
    Cancer Treat Rep; 1985 Sep; 69(9):1035-6. PubMed ID: 4028037
    [No Abstract] [Full Text] [Related]

  • 12. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
    Tilchen EJ, Fleming T, Mills G, Oishi N, Bonnett JD, Natale RB, Harker G, Coltman CA.
    Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548
    [No Abstract] [Full Text] [Related]

  • 13. Phase II trial of diaziquone in advanced renal adenocarcinoma.
    Hansen M, Gallmeier WM, Vermorken J, Holdener E, Hansen HH, Renard J, Rozencweig M.
    Cancer Treat Rep; 1984 Dec; 68(7-8):1055-6. PubMed ID: 6744342
    [No Abstract] [Full Text] [Related]

  • 14. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S, Spaulding M, Bhimani S, Avellanosa A, DeLos Santos R, Perry A, Zeigler P, Kirshner J.
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract] [Full Text] [Related]

  • 15. Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
    Cancer Treat Rep; 1987 Sep; 71(9):865-7. PubMed ID: 3476203
    [No Abstract] [Full Text] [Related]

  • 16. Phase II trial of diaziquone in patients with colon cancer.
    Neidhart JA, Erlichman C, Robert F, Velez-Garcia E, Bender JF, Grillo-López J.
    Cancer Treat Rep; 1985 Feb; 69(2):215-7. PubMed ID: 3882229
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of aziridinylbenzoquinone (AZQ) in head and neck cancer.
    Forastiere AA, Crain SM, Callahan K, Van Echo D, Mattox D, Thant M, Von Hoff DD, Wiernik PH.
    Cancer Treat Rep; 1982 Dec; 66(12):2097-8. PubMed ID: 6892491
    [No Abstract] [Full Text] [Related]

  • 18. Phase II trial of diaziquone in patients with refractory and relapsing multiple myeloma: a Southwest Oncology Group Study.
    Stuckey WJ, Crowley J, Baker LH, Larrimer NR, Hanson KH, Bonnet JD, White LA.
    Cancer Treat Rep; 1987 Nov; 71(11):1095-6. PubMed ID: 3119202
    [No Abstract] [Full Text] [Related]

  • 19. Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
    Carey RW, Comis RL, Anbar D, Kennedy BJ, Capizzi RL, Shulman P, Booth BW, Green M, Raich PC.
    Cancer Treat Rep; 1983 Jan; 67(1):95-6. PubMed ID: 6616498
    [No Abstract] [Full Text] [Related]

  • 20. Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B.
    Vinciguerra V, Anderson K, McIntyre OR.
    Cancer Treat Rep; 1985 Mar; 69(3):331-2. PubMed ID: 3884154
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.